Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
3642 | 1862 | 30.2 | 86% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
1292 | 8181 | FOCAL NODULAR HYPERPLASIA//GD EOB DTPA//GADOXETIC ACID |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | GD EOB DTPA | Author keyword | 249 | 80% | 8% | 154 |
2 | GADOXETIC ACID | Author keyword | 146 | 81% | 5% | 87 |
3 | GADOXETATE DISODIUM | Author keyword | 44 | 71% | 2% | 36 |
4 | HEPATOBILIARY PHASE | Author keyword | 35 | 86% | 1% | 18 |
5 | LIVER NEOPLASMS MR | Author keyword | 31 | 39% | 3% | 62 |
6 | LIVER MR | Author keyword | 29 | 38% | 3% | 62 |
7 | MANGAFODIPIR TRISODIUM | Author keyword | 27 | 74% | 1% | 20 |
8 | GADOXETATE | Author keyword | 24 | 91% | 1% | 10 |
9 | HEPATOCYTE PHASE | Author keyword | 17 | 100% | 0% | 8 |
10 | LIVER MRI | Author keyword | 16 | 46% | 1% | 25 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | GD EOB DTPA | 249 | 80% | 8% | 154 | Search GD+EOB+DTPA | Search GD+EOB+DTPA |
2 | GADOXETIC ACID | 146 | 81% | 5% | 87 | Search GADOXETIC+ACID | Search GADOXETIC+ACID |
3 | GADOXETATE DISODIUM | 44 | 71% | 2% | 36 | Search GADOXETATE+DISODIUM | Search GADOXETATE+DISODIUM |
4 | HEPATOBILIARY PHASE | 35 | 86% | 1% | 18 | Search HEPATOBILIARY+PHASE | Search HEPATOBILIARY+PHASE |
5 | LIVER NEOPLASMS MR | 31 | 39% | 3% | 62 | Search LIVER+NEOPLASMS++MR | Search LIVER+NEOPLASMS++MR |
6 | LIVER MR | 29 | 38% | 3% | 62 | Search LIVER++MR | Search LIVER++MR |
7 | MANGAFODIPIR TRISODIUM | 27 | 74% | 1% | 20 | Search MANGAFODIPIR+TRISODIUM | Search MANGAFODIPIR+TRISODIUM |
8 | GADOXETATE | 24 | 91% | 1% | 10 | Search GADOXETATE | Search GADOXETATE |
9 | HEPATOCYTE PHASE | 17 | 100% | 0% | 8 | Search HEPATOCYTE+PHASE | Search HEPATOCYTE+PHASE |
10 | LIVER MRI | 16 | 46% | 1% | 25 | Search LIVER+MRI | Search LIVER+MRI |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | GD EOB DTPA | 426 | 73% | 17% | 322 |
2 | HEPATOBILIARY PHASE | 103 | 91% | 2% | 42 |
3 | MN DPDP | 99 | 65% | 5% | 94 |
4 | GADOXETIC ACID | 86 | 80% | 3% | 53 |
5 | CIRRHOTIC LIVER | 77 | 42% | 8% | 142 |
6 | DYSPLASTIC NODULES | 66 | 41% | 7% | 126 |
7 | GADOBENATE DIMEGLUMINE | 66 | 40% | 7% | 130 |
8 | CIRRHOTIC LIVERS | 58 | 50% | 5% | 84 |
9 | FOCAL LIVER LESIONS | 56 | 30% | 8% | 158 |
10 | GADOLINIUM ETHOXYBENZYL DTPA | 53 | 95% | 1% | 18 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma A Systematic Review and Meta-analysis | 2015 | 2 | 170 | 53% |
Hepatocellular Carcinoma: Diagnostic Performance of Multidetector CT and MR Imaging-A Systematic Review and Meta-Analysis | 2015 | 1 | 56 | 70% |
Primovist, Eovist: What to expect? | 2012 | 40 | 78 | 65% |
Gadoxetate Disodium-Enhanced MRI of the Liver: Part 2, Protocol Optimization and Lesion Appearance in the Cirrhotic Liver | 2010 | 66 | 40 | 80% |
CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma. Part II. Extracellular Agents, Hepatobiliary Agents, and Ancillary Imaging Features | 2014 | 4 | 146 | 64% |
Hepatic MRI with SPIO: detection and characterization of focal liver lesions | 1998 | 100 | 34 | 88% |
Gadoxetate Disodium-Enhanced MRI of the Liver: Part 1, Protocol Optimization and Lesion Appearance in the Noncirrhotic Liver | 2010 | 88 | 65 | 49% |
MR Imaging of hepatocellular carcinoma in the cirrhotic liver: Challenges and controversies | 2008 | 145 | 190 | 35% |
Hepatobiliary MR imaging with gadolinium-based contrast agents | 2012 | 23 | 99 | 58% |
CT and MR Imaging Diagnosis and Staging of Hepatocellular Carcinoma: Part I. Development, Growth, and Spread: Key Pathologic and Imaging Aspects | 2014 | 4 | 133 | 46% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | MED AFFAIRS DIAGNOST IMAGING | 3 | 100% | 0.2% | 3 |
2 | LIVER IMAGING GRP | 3 | 23% | 0.6% | 11 |
3 | PHYSIOPATHOL HEPAT IMAGERIE MOL | 3 | 33% | 0.4% | 7 |
4 | KLIN PHARMAKOL TOXICOL | 2 | 44% | 0.2% | 4 |
5 | DIAGNOST IMAGING MED AFFAIRS | 2 | 67% | 0.1% | 2 |
6 | IMAGING DIAG INTERVENT RADIOL | 2 | 43% | 0.2% | 3 |
7 | INSERM UMR 773 | 1 | 100% | 0.1% | 2 |
8 | MOL IMAGING DIAG | 1 | 18% | 0.3% | 6 |
9 | ABT RADIOL BILDGEBENDE DIAGNOST | 1 | 40% | 0.1% | 2 |
10 | BUNNKYOU KU | 1 | 40% | 0.1% | 2 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000228719 | ADENOMATOUS HYPERPLASIA//MACROREGENERATIVE NODULES//LIVER CELL DYSPLASIA |
2 | 0.0000173926 | TEST BOLUS//SALINE CHASER//IODINE CONCENTRATION |
3 | 0.0000172477 | PORTOGRAPHY//ARTERIAL PORTOGRAPHY//LIVER ANATOMY |
4 | 0.0000148712 | SSFP//RAPID IMAGING//TRUEFISP |
5 | 0.0000127366 | CONTRAST ENHANCED ULTRASOUND//CONTRAST ENHANCED ULTRASONOGRAPHY//SONAZOID |
6 | 0.0000117437 | FOCAL NODULAR HYPERPLASIA//HEPATOCELLULAR ADENOMA//HEPATIC ADENOMA |
7 | 0.0000110795 | INTRAVOXEL INCOHERENT MOTION//DIFFUSION WEIGHTED IMAGING//APPARENT DIFFUSION COEFFICIENT |
8 | 0.0000085202 | LYMPHATIC SYSTEM MR//LYMPHOGRAPHY//INTERSTITIAL MR LYMPHOGRAPHY |
9 | 0.0000078548 | MEMRI//MANGANESE ENHANCED MRI//MANGANESE ENHANCED MAGNETIC RESONANCE IMAGING |
10 | 0.0000076974 | NEPHROGENIC SYSTEMIC FIBROSIS//NEPHROGENIC FIBROSING DERMOPATHY//GADOLINIUM |